International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a global pharmaceutical industry association representing innovative pharmaceutical companies and associations worldwide. Founded in 1968 and headquartered in Geneva, Switzerland, IFPMA serves as a leading voice for the biopharmaceutical industry, promoting policies that support medical innovation, patient access, and sustainable healthcare development.

IFPMA represents research-based pharmaceutical companies involved in the discovery, development, and delivery of innovative medicines and vaccines. Its members include global pharmaceutical companies and national industry associations from different regions around the world.

The organization works on major healthcare issues including research and development, global health policy, regulatory science, vaccine access, antimicrobial resistance, intellectual property protection, and healthcare innovation. IFPMA collaborates with governments, international organizations, healthcare stakeholders, and patient groups to improve healthcare outcomes worldwide.

IFPMA plays an important role in promoting ethical business practices, responsible innovation, and scientific collaboration across the pharmaceutical sector. The organization develops industry standards, policy recommendations, and position statements on topics affecting medicine development and healthcare systems.

Through partnerships with organizations such as the World Health Organization (WHO), regulatory authorities, and global health institutions, IFPMA contributes to discussions on improving access to safe, effective, and innovative medicines.

The federation supports pharmaceutical innovation by advocating for strong research ecosystems, sustainable healthcare policies, and collaboration between industry, governments, and scientific communities.

With decades of experience representing the global pharmaceutical sector, IFPMA continues to influence healthcare policy and support advancements that help bring new treatments and therapies to patients worldwide.